1 / 25

Out With the Old and In With the New, Again?

Out With the Old and In With the New, Again?. Out With the Old, In With the New. Current Standard of Care. NEUTRINO and FISSION SOF + RBV ± pegIFN for Treatment-naive Patients. NEUTRINO and FISSION SOF + RBV ± pegIFN for Treatment-naive Patients.

sulwyn
Télécharger la présentation

Out With the Old and In With the New, Again?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Out With the Old and In With the New, Again?

  2. Out With the Old, In With the New

  3. Current Standard of Care

  4. NEUTRINO and FISSIONSOF + RBV ± pegIFN for Treatment-naive Patients

  5. NEUTRINO and FISSIONSOF + RBV ± pegIFN for Treatment-naive Patients

  6. FUSIONSOF + RBV ± pegIFN in Treatment-experienced Patients With G2,3 HCV

  7. VALENCESOF + RBV for 12 Weeks or 24 Weeks in G2 or G3 HCV Infection

  8. QUEST 1 and 2Q80K Variant Adversely Affects SVR12 of SMV-based Therapy

  9. COSMOS SOF + SIM ± RBV for G1 HCV-infected Patients by Fibrosis Stage

  10. 2014 AASLD HCV Treatment Guidelines

  11. ION-1On the Road to IFN-free Therapy for G1 HCV Infection

  12. ION-38 Weeks or 12 Weeks of SOF/LDV for Treatment-naive G1 HCV Infection

  13. ION-2SOF/LDV in G1 HCV-infected Patients Failing PegIFN/RBV ± DAA

  14. HALLMARK-DUALPhase 3 Trial of the All-oral Regimen DCV + ASV for G1b HCV Infection

  15. SAPPHIRE IABT-450/r/Ombitasvir + Dasabuvir (3D) + RBV for G1 HCV Infection

  16. SAPPHIRE IIABT-450/r/Ombitasvir + Dasabuvir + RBV (3D) G1 HCV

  17. TURQUOISE IIABT-450/r/Ombitasvir + Dasabuvir (3D) + RBV in Cirrhosis

  18. The Past And Future of HCV Therapy

  19. Abbreviations

  20. Abbreviations (cont)

  21. Abbreviations (cont)

  22. References

  23. References (cont)

  24. References (cont)

  25. References (cont)

More Related